Reproductive Tumor Pathology Flashcards
Answer D
This patient with vaginal bleeding, endometrial hyperplasia, and a unilateral adnexal mass has pathologic features consistent with a granulosa cell tumor (GCT). GCTs are a type of ovarian sex-cord stromal tumor (derived from cells that support and surround the developing oocyte) that are most often seen in postmenopausal patients.
GCTs secrete estrogen and inhibin. Unopposed estrogen leads to endometrial hyperplasia (eg, postmenopausal bleeding, thickened endometrium on ultrasound), with increased cellular division that increases the risk of endometrial carcinoma.
Gross inspection typically shows a large, unilateral, solid and cystic mass, which may appear yellow (because of intracellular lipid content). Microscopically, GCTs show a proliferation of neoplastic granulosa cells (eg, small, cuboidal cells with nuclear grooves [ie, coffee bean nuclei]) and variable architectural patterns (eg, sheets, cords). The granulosa cells characteristically form follicle- or rosette-like structures around central eosinophilic material (ie, Call-Exner bodies).
(Choice A) Alpha-fetoprotein is normally produced by the fetal liver and yolk sac, but it is also a tumor marker in patients with hepatocellular, nonseminomatous testicular, or ovarian tumors (eg, yolk sac tumor). Yolk sac tumors typically occur in young women, and histopathology may show Schiller-Duval bodies, which resemble glomeruli.
(Choice B) β-hCG is used to confirm pregnancy and screen for gestational trophoblastic disease and germ cell tumors (eg, choriocarcinoma). Histopathology of choriocarcinoma shows syncytiotrophoblasts and cytotrophoblasts.
(Choice C) Cancer antigen 125 (CA-125) is elevated in epithelial carcinomas of the ovary (eg, serous). Histopathology of serous carcinoma often shows markedly atypical cells that line complex papillary structures and invade the ovarian stroma. Psammoma bodies may also be seen.
(Choice E) Testosterone is produced by Sertoli-Leydig tumors, another type of ovarian sex-cord stromal tumor. Affected patients show evidence of hyperandrogenism (eg, hirsutism, clitoromegaly, deepening voice).
(Choice F) Struma ovarii is an ovarian germ cell tumor that can cause hyperthyroidism by secreting thyroxine. Histopathology shows mature thyroid tissue (eg, follicular epithelial cells surrounding colloid); endometrial hyperplasia would not be expected.
Educational objective:
Granulosa cell tumors are ovarian sex-cord stromal tumors that often secrete estrogen (eg, postmenopausal bleeding, endometrial hyperplasia). Gross pathology typically shows a large, unilateral, solid and cystic mass, which may appear yellow. Call-Exner bodies (ie, neoplastic granulosa cells forming follicle-like structures around central eosinophilic material) are often seen on microscopy.
Answer E
This patient with oligomenorrhea, signs of hyperandrogenism (eg, acne, hirsutism), and infertility likely has polycystic ovary syndrome (PCOS). PCOS is characterized by increased ovarian androgen production, which acts on the hypothalamic-pituitary-ovarian (HPO) axis to cause an abnormally elevated LH/FSH ratio that inhibits ovulation. Therefore, a common presentation is irregular menses with anovulatory infertility. Obesity, which is common with PCOS, can also contribute to the anovulatory state by inducing hyperinsulinism, which acts synergistically in the ovary with LH to upregulate androgen production.
In addition to increased androgen levels, PCOS causes increased estrogen levels due to androgen-to-estrogen conversion by the enzyme aromatase within the ovary (eg, estradiol) and adipose tissue (eg, estrone). Estrogen normally stimulates endometrial proliferation to allow for implantation. Progesterone, which is released after ovulation, opposes endometrial proliferation by inducing cellular differentiation, protecting against endometrial hyperplasia.
Women with PCOS have disproportionately high estrogen production but low progesterone release (ie, unopposed estrogen exposure) due to chronic anovulation, resulting in unregulated, increasingly disordered endometrial proliferation and increased risk for endometrial hyperplasia and carcinoma.
(Choice A) Adrenal atrophy presents with severe fatigue, weight loss, and low blood pressure due to glucocorticoid and mineralocorticoid deficiency. In contrast to PCOS (which is associated with hirsutism), women may experience axillary and pubic hair loss due to adrenal androgen deficiency.
(Choice B) Various disorders (eg, endometriosis, pelvic inflammatory disease) can cause chronic pelvic pain by inducing pelvic inflammation and tissue fibrosis. However, PCOS does not typically cause pelvic inflammation or pain.
(Choice C) Patients with Cushing syndrome have symptoms similar to those of patients with PCOS such as obesity, menstrual irregularities, and increased body hair. However, additional findings such as hypertension, abdominal striae, and supraclavicular fat pads are also typically seen due to the excess cortisol.
(Choice D) Having another autoimmune disease (eg, Hashimoto thyroiditis) increases the risk of type 1 diabetes mellitus. Although PCOS is a risk factor for type 2 diabetes mellitus (due to increased insulin resistance), it is not associated with type 1 diabetes mellitus.
(Choice F) The primary risk factor for vaginal intraepithelial neoplasia is persistent human papillomavirus infection.
Educational objective:
Polycystic ovary syndrome can present with irregular menses, hyperandrogenism (eg, acne, hirsutism), and anovulatory infertility. Patients are at increased risk for endometrial hyperplasia and carcinoma due to increased estrogen production and chronic anovulation.
Answer E
This patient has biopsy-confirmed squamous cell carcinoma of the cervix as a result of human papillomavirus (HPV) infection. HPV is a small double-stranded DNA virus with multiple genotypes. High-risk subtypes 16 and 18 are the most common identified in cervical cancers.
The oncogenic capability of HPV is dependent on its ability to integrate into the host genome and subsequently produce viral proteins E6 and E7, which interact with cell cycle regulatory proteins p53 and Rb, respectively. E6 binds p53, leading to its ubiquination and subsequent proteasomal degradation. Without p53, the cell is unable to halt cell growth to repair damaged DNA or trigger apoptosis when DNA is damaged beyond repair. Similarly, E7 binds Rb and displaces bound transcription factors, promoting unregulated DNA replication and cyclin-mediated cell cycling. The collective effects of E6 and E7 lead to inhibition of cell cycle regulation and evasion of apoptosis, consequently increasing malignant potential.
(Choice A) RAS and BRAF are proto-oncogenes that code for cytoplasmic signal transducer proteins, which upregulate cellular proliferation and differentiation when activated. Mutations causing constitutive activation of these proteins are linked to development of pancreatic cancer (Ras) and malignant melanomas (BRAF).
(Choice B) Mutations resulting in upregulation of the epithelial growth factor receptor (EGFR) gene have been implicated in the development of solid tumors (eg, colon, breast, lung).
(Choice C) MSH2 is a DNA mismatch repair protein encoded by the MSH2 gene, which leads to ineffective DNA repair when inactivated. This is the pathogenic basis of hereditary nonpolyposis colorectal cancer (HNPCC).
(Choice D) Platelet derived growth factor (PDGF) activity is essential for normal development of the central nervous system during the embryonic period. Upregulation of PDGF synthesis and corresponding receptor activation are responsible for the malignant transformation of glial cells in glioblastoma.
Educational objective:
Human papillomavirus (HPV) oncogenicity relies on the inhibitory effects of viral proteins E6 and E7 on cell cycle regulatory proteins p53 and Rb. This allows cells infected with HPV to undergo unchecked cellular proliferation and evasion of apoptosis, promoting genomic instability and malignant transformation.
A 48-year-old woman comes to the office due to painful, heavy menses for the past 6 months. The patient has 4-5 days of heavy bleeding, often soaking through a tampon or sanitary napkin every few hours. Menstrual periods occur every 28-30 days. The patient is not on contraception and has no significant medical history. Vital signs are normal. Urine pregnancy test is negative. After an appropriate workup, a hysterectomy is performed, and the surgical specimen is shown below:
Which of the following is the most likely diagnosis?
A. Adenomyosis
B. Chronic endometritis
C. Complete hydatidiform mole
D. Endometriosis
E. Uterine leiomyoma
F. Uterine sarcoma
Answer A
This patient with heavy menses and dysmenorrhea has adenomyosis, the abnormal presence of endometrial glands and stroma within the uterine myometrium (ie, uterine wall). Adenomyosis typically occurs in women age >40, and risk factors include multiparity and prior uterine surgery (eg, cesarean delivery).
The pathology of adenomyosis correlates with its clinical symptoms. Adenomyosis has a gross appearance as areas of dark red endometrial tissue within the myometrium. With each menstrual cycle, the endometrial tissue proliferates and sheds but the bleeding is confined within the uterine wall, causing dysmenorrhea. In addition, the ectopic endometrial glands induce myometrial hyperplasia and hypertrophy, creating a globular, uniformly enlarged uterus. This uterine enlargement also increases the surface area of the endometrial cavity, resulting in regular, heavy menses (eg, every 28-30 days). Definitive treatment is with hysterectomy.
(Choice B) Chronic endometritis is an intrauterine polymicrobial infection that typically causes constant pelvic pain with irregular bleeding rather than dysmenorrhea and regular, heavy menses. Because the disease process is intracavitary, there is no associated uterine enlargement. Gross pathology may reveal intrauterine adhesions due to chronic intrauterine inflammation.
(Choice C) A complete hydatidiform mole typically causes amenorrhea or irregular, first-trimester bleeding rather than regular, heavy menses. In addition, patients typically have markedly elevated β-hCG levels (ie, >100,000 mIU/mL). Gross pathology may reveal uterine enlargement, but there are typically numerous edematous intrauterine chorionic villi.
(Choice D) Endometriosis is a common cause of dysmenorrhea due to ectopic implantation of endometrial glands and stroma in the abdominopelvic cavity; because the ectopic implants are extrauterine, patients do not have uterine enlargement or heavy menses. Gross pathology typically reveals black powder–burn lesions or ovarian cysts (ie, endometrioma).
(Choice E) Uterine leiomyomas are benign, uterine smooth muscle cell tumors that can cause regular, heavy menses. However, gross pathology typically reveals an irregularly enlarged uterus with discrete tumors rather than a uniformly globular uterus.
(Choice F) Uterine sarcomas are malignant uterine tumors. Affected patients typically have irregular, postmenopausal bleeding rather than regular, heavy menses. Gross pathology typically reveals a discrete uterine mass.
Educational objective:
Adenomyosis typically presents with regular (ie, cyclic), heavy, painful menses. Gross pathology reveals a uniformly enlarged, globular uterus with the abnormal presence of endometrial glands and stroma in the myometrium.
Answer E
This patient has symptomatic uterine fibroids (ie, leiomyomas), which are benign, estrogen-dependent tumors that can cause bulk (eg, pelvic pressure, constipation) or bleeding symptoms such as heavy menses and blood loss anemia.
Patients with symptomatic fibroids may be treated with leuprolide, a GnRH receptor agonist that initially stimulates gonadotropin (ie, FSH, LH) secretion from the pituitary. However, unlike endogenous GnRH (which is released in a pulsatile fashion), continuous leuprolide therapy (eg, depot injection formulations) eventually causes desensitization and downregulation of pituitary GnRH receptors, leading to decreased FSH (hypogonadotropic) and decreased estrogen (hypogonadal) levels. Over time, leuprolide’s feedback inhibition at the hypothalamic level also leads to decreased endogenous GnRH release.
The hypogonadotropic, hypogonadal state induced by leuprolide can shrink estrogen-dependent fibroids and induce amenorrhea, thereby improving bleeding symptoms.
(Choice A) Clomiphene, used for ovulation induction to treat infertility, acts on the hypothalamus by interfering with hypothalamic estrogen receptors, thereby inhibiting normal negative feedback from estrogen; this promotes GnRH and FSH secretion and stimulates ovulation.
(Choice B) Letrozole, an aromatase inhibitor, decreases peripheral (ie, adipose) and ovarian conversion of androgens to estrogens; the decreased estrogen level releases estrogenic negative feedback on the hypothalamus to increase GnRH and FSH secretion. Letrozole is used as adjuvant therapy for estrogen receptor–positive breast cancer in postmenopausal women (by decreasing estrogen levels) and for ovulation induction (by stimulating GnRH and FSH release).
(Choice C) Depot medroxyprogesterone acetate (DMPA), a progesterone contraceptive, inhibits pituitary secretion of gonadotropins (ie, FSH, LH) to prevent ovulation. The decrease in FSH causes increased hypothalamic GnRH secretion and suppressed ovarian estrogen production.
(Choice D) Exogenous estrogen–containing medications (eg, combined estrogen-progestin oral contraceptives, menopausal hormone therapy) increase estrogen levels, producing negative feedback at the hypothalamus and decreased GnRH and FSH levels.
Educational objective:
Leuprolide is a GnRH agonist used to treat symptomatic uterine fibroids (eg, heavy menses, anemia). When administered in a continuous fashion, leuprolide inhibits the release of endogenous hypothalamic GnRH and downregulates pituitary GnRH receptors, thereby decreasing GnRH, FSH, and estrogen levels (ie, hypogonadotropic hypogonadism).
Answer D
Endometriosis refers to the implantation of ectopic endometrial tissue outside of the uterus (commonly within the pelvis) and may present with pelvic pain, dysmenorrhea, and infertility. Definitive diagnosis is made by surgical biopsy with microscopic examination. Histologic features of endometriosis include endometrial glands (lined by columnar epithelium), endometrial stroma, and hemosiderin (due to breakdown of accumulated blood).
This patient’s biopsy reveals endometriosis involving the ovary. The surface of the ovary is covered by a simple cuboidal epithelium, which is a modified mesothelium and is continuous with the peritoneum. The ovarian surface epithelium is thought to take part in the repair of surface defects created by ovulation.
On cross section, the ovary contains an outer cortex surrounding an inner medulla. The cortex shows ovarian stroma (storiform pattern of blue, spindled stromal cells) with interspersed follicles seen at different developmental states. The mature follicle consists of an oocyte (germ cell) encircled by granulosa and theca cells, which support the oocyte throughout follicle development. The medulla is predominantly composed of blood vessels and nerves within loose connective tissue.
(Choice A) The ectocervix is lined by nonkeratinized stratified squamous epithelium, and the endocervix is lined by simple columnar epithelium. The area where ectocervical squamous epithelium transitions to endocervical columnar epithelium is termed the squamocolumnar junction.
(Choice B) Endometrial mucosa covers the uterine cavity and consists of endometrial glands (lined by columnar cells) with surrounding stroma.
(Choice C) The mucosal folds and fimbriae of the fallopian tube are lined by simple columnar epithelial cells, some of which are ciliated and function to transport the egg or embryo toward the uterus.
(Choice E) The vagina is lined by nonkeratinized stratified squamous epithelium.
Educational objective:
Histologic features of endometriosis include endometrial glands (lined by columnar epithelium), endometrial stroma, and hemosiderin. Endometriosis commonly involves the ovary, which is covered by a simple cuboidal surface epithelium.
Answer F
Patients with endometriosis have painful menses due to extrauterine endometrial implants, which shed with menses and cause intraperitoneal irritation. Treatment aims to suppress menstruation by decreasing the activity of the hypothalamic-pituitary-ovarian axis (HPO axis).
Leuprolide is a GnRH receptor agonist (ie, GnRH analogue) that can be administered in either a pulsatile (mimicking endogenous GnRH secretion) or continuous fashion. Leuprolide, when administered continuously and over a prolonged duration, produces 2 distinct hormonal patterns:
Initially (ie, day 3), the GnRH receptor agonist effect of leuprolide stimulates the HPO axis; this causes increased FSH and estrogen secretion without a significant change in GnRH levels.
With prolonged use (ie, day 60), leuprolide causes desensitization and downregulation of pituitary GnRH receptors, which eventually leads to low FSH and estrogen levels. Because leuprolide is an exogenous GnRH analogue, its prolonged use also decreases endogenous GnRH levels.
The resulting hypogonadotropic, hypogonadal state induces amenorrhea, thereby improving dysmenorrhea associated with endometriosis.
(Choice A) Clomiphene competitively binds to hypothalamic estrogen receptors, which prevents estrogenic negative feedback. Therefore, GnRH, FSH, and estrogen levels are all elevated following treatment.
(Choice B) Danazol is primarily an androgen receptor agonist but can also suppress FSH and LH release from the anterior pituitary. Therefore, both FSH and estrogen would be low, and GnRH levels may be elevated due to reduced feedback inhibition.
(Choices C and D) Ethinyl estradiol and etonogestrel are a synthetic estrogen and progestin, respectively. These medications suppress both the hypothalamus and anterior pituitary gland, resulting in decreased GnRH, FSH, and estrogen levels. In this case, the study participants’ initially elevated FSH and estrogen levels are more consistent with administration of a GnRH analogue.
(Choice E) Letrozole, an aromatase inhibitor, inhibits androgen-to-estrogen conversion. Therefore, estrogen levels are low initially, which stimulates high GnRH and FSH levels. Over time, high FSH levels eventually stimulate increased estrogen production, which mostly restores estrogenic negative feedback; therefore, GnRH, FSH, and estrogen levels may normalize by day 60.
Educational objective:
Continuously administered GnRH receptor agonists (eg, leuprolide) initially stimulate pituitary FSH and ovarian estrogen secretion. However, prolonged use eventually inhibits endogenous GnRH release and downregulates pituitary GnRH receptors, causing decreased GnRH, FSH, and estrogen levels. The resulting hypogonadotropic, hypogonadal state induces amenorrhea, thereby improving dysmenorrhea associated with endometriosis.
Answer D
This patient has lower abdominal pain and vaginal bleeding. In the setting of a positive pregnancy test (eg, detectable β-hCG) and an adnexal mass, her presentation is most concerning for ectopic pregnancy.
Following ovulation, the ovum normally travels along the length of the fallopian tube where it can be fertilized by a sperm cell. The fertilized ovum continues through the fallopian tube, developing into a blastocyst, and subsequently implants on the uterine endometrium. However, migration of the fertilized ovum is occasionally impeded, resulting in implantation in the fallopian tube (~90%) or other extrauterine locations. Ectopic pregnancy often occurs secondary to tubal pathology (eg, pelvic inflammatory disease, prior pelvic surgery) but can present in patients without risk factors.
After implantation in the fallopian tube, the ectopic pregnancy develops into a highly vascular adnexal mass that draws blood flow from surrounding tissues to maintain its rapid growth. This causes ischemic injury to surrounding tissues, fallopian tube edema, and potential tubal rupture, resulting in the classic symptoms of pelvic cramping and vaginal bleeding (eg, spotting).
(Choice A) A hydatidiform mole can occur due to abnormal ovum fertilization by 2 sperm and may present with vaginal bleeding and adnexal enlargement (ie, theca lutein cyst formation due to β-hCG stimulation). Patients typically have an enlarged uterus (due to abundant growth of chorionic villi) and markedly elevated β-hCG levels (>100,000 mIU/mL), neither of which is seen in this patient.
(Choice B) Uterine leiomyoma (ie, fibroids) are tumors arising from benign proliferation of the myometrium. Although they can cause cramping and vaginal bleeding, fibroids usually present with uterine enlargement or an abnormal uterine contour, which are not seen in this patient. In addition, fibroids are not associated with elevated β-hCG levels.
(Choice C) An endometrioma, or ectopic endometrial tissue in the ovary, can cause an adnexal mass and vaginal bleeding if ruptured. However, patients typically have dysmenorrhea and additional symptoms associated with endometriosis (eg, dyspareunia, dyschezia).
(Choice E) Ovarian torsion can occur in patients with a mature teratoma (an ovarian mass composed of ectoderm, endoderm, and mesoderm). Although torsion can cause pelvic pain and a palpable adnexal mass, the pain is typically sudden and unilateral and vaginal bleeding is uncommon.
Educational objective:
Ectopic pregnancy occurs when a fertilized embryo implants in an extrauterine location (eg, the fallopian tube). Patients can have pelvic cramping, vaginal bleeding, and a palpable adnexal mass.
Answer D
Cervical intraepithelial neoplasia (CIN) represents a spectrum of dysplastic changes that can lead to cervical cancer. CIN and cervical cancer are strongly related to human papillomavirus (HPV) infection, which directly promotes epithelial cell dysplasia via integration and expression of viral oncogenes.
Risk factors for CIN/cervical cancer include increased exposure to HPV and impaired immunity, which both increase the likelihood of persistent HPV infection and ongoing cervical dysplasia:
Increased HPV exposure: Most HPV infections are acquired by skin-to-skin contact, but types 16 and 18 (responsible for most cases of CIN/cancer) are usually sexually transmitted. Therefore, patients with an early onset of sexual activity, multiple or high-risk sexual partners, and lack of barrier contraceptive (condom) use are more likely to be exposed to oncogenic HPV types.
Immunosuppression: In patients with an intact immune system, most HPV infections are transient. However, patients with impaired cellular immunity (eg, HIV coinfection, tobacco use) are more likely to have persistent HPV infection.
The correct and consistent use of condoms reduces contact during sexual activity and lowers the likelihood of HPV infection via sexual transmission. Vaccination also decreases the risk for persistent HPV infection and therefore CIN/cervical cancer.
(Choices A and E) Early menarche and nulliparity increase the risk for endometrial, not cervical, cancer. These factors are associated with increased lifetime estrogen exposure, which stimulates endometrial proliferation.
(Choice B) Family history is a risk factor for endometrial cancer (eg, Lynch syndrome) but not for cervical cancer, which is usually due to persistent HPV infection.
(Choice C) Plantar warts (verruca vulgaris) are common in children and young adults. However, they are most often caused by infection with HPV types 1-4, which are not associated with cervical dysplasia or invasive cervical cancer.
(Choice F) Research on douching and HPV infection rates demonstrates mixed results; that is, douching-induced epithelial injury may increase HPV transmission, whereas postcoital douching may decrease transmission. In general, douching is not a significant risk factor for persistent HPV infection.
Educational objective:
Human papillomavirus (HPV) infections, particularly types 16 and 18, are the primary cause of cervical dysplasia and cancer. The risk is higher in patients with increased HPV exposure (eg, multiple sexual partners, lack of barrier contraception use) or impaired immunity (eg, HIV) due to persistent HPV infection.
Answer C
This patient with constipation, pelvic pressure, and an irregularly enlarged uterus likely has a uterine leiomyoma. Leiomyomas (ie, fibroids) are monoclonal tumors; each fibroid is derived from a distinct progenitor cell. They can be located on the serosal surface of the uterus (subserosal), within the uterine wall (intramural), and beneath the endometrium (submucosal).
Subserosal fibroids typically cause greater uterine irregularity and enlargement compared to intramural or submucosal fibroids, which are more constrained by uterine tissue. Because the uterus is located posterior to the bladder and anterior to the rectosigmoid colon, irregular uterine enlargement from fibroids can put pressure on these adjacent organs, causing bulk-related symptoms (eg, pelvic pressure). Fibroids in the posterior uterus can put pressure on the colon, leading to constipation.
Additional symptoms vary, depending on location. Anterior subserosal fibroids may cause obstructive urinary symptoms (eg, urgency, incomplete emptying). Other types (eg, submucosal or intramural) can lead to reproductive difficulties due to distortion of the endometrial cavity. Submucosal fibroids in particular can cause prolonged and/or heavy menstrual bleeding.
(Choice A) Adenomyosis typically presents with dysmenorrhea, heavy menstrual bleeding, and a diffusely tender, uniformly globular uterus rather than an irregularly enlarged uterus. It is not associated with constipation.
(Choice B) Advanced-stage cervical cancer may cause bulk-related symptoms such as constipation and pelvic pressure. However, patients typically have abnormal bleeding (eg, postcoital bleeding) or a visible cervical lesion.
(Choice D) Pelvic organ prolapse is the herniation of pelvic structures through the vagina due to pelvic floor weakening. Although posterior vaginal wall prolapse (ie, rectocele) can cause pelvic pressure and constipation, it does not cause uterine enlargement. In addition, premenopausal, nonobese, nulliparous women are at low risk for pelvic organ prolapse.
(Choice E) Rectovaginal endometriosis, ectopic implants of endometrial glands and stroma, may cause pelvic pain and constipation, especially around menses. However, dyspareunia (ie, pain with intercourse), dyschezia, and a palpable, tender nodularity are typically present.
Educational objective:
Subserosal uterine leiomyomas (fibroids) can cause irregular uterine enlargement and bulk-related symptoms (eg, pelvic pressure). Posterior leiomyomas can cause constipation due to pressure on the colon.
A 73-year-old woman comes to the office due to increasing abdominal girth. She also has constipation and decreased appetite that has worsened progressively for the last 6 months. On physical examination, the abdomen is distended and nontender, and there is a palpable right adnexal mass. The patient undergoes a right oophorectomy, and gross and microscopic examinations of the specimen are shown in the exhibit. Which of the following markers is most likely to be elevated in this patient?
A. Alpha-fetoprotein
B. β-hCG
C. Cancer antigen 125
D. Estrogen
E. Lactate dehydrogenase
F. Testosterone
Answer C
Patients with ovarian cancer can present with a pelvic mass, ascites, and peritoneal metastasis that result in decreased appetite, abdominal distension, and bowel or bladder changes (eg, constipation, urinary frequency).
Ovarian cancer has 3 histologic types: epithelial, germ cell, and sex cord–stromal. Epithelial ovarian cancer is the most common subtype, and histologic findings include anaplasia of epithelial cells with invasion into the stroma, multiple papillary formations with cellular atypia, and occasional psammoma bodies.
Epithelial ovarian cancer is associated with elevated cancer antigen 125 (CA-125) levels. CA-125 is a protein expressed and released by cells from the peritoneum and müllerian structures (eg, uterus, fallopian tubes) that surround the ovaries. Conditions that irritate or stimulate these cells, either benign (eg, endometriosis) or malignant (eg, epithelial ovarian cancer), cause CA-125 levels to rise. Therefore, in patients with an ovarian mass, an elevated CA-125 level often indicates a rapid-growth tumor irritating the peritoneal tissue or other pelvic structures.
(Choice A) Serum alpha-fetoprotein levels may be increased in patients with hepatocellular carcinoma and ovarian germ cell tumors (eg, endodermal sinus [yolk sac] tumor). Endodermal sinus tumors of the ovary demonstrate Schiller-Duval bodies, which resemble glomeruli.
(Choices B and E) β-hCG is elevated in normal pregnancy, gestational trophoblastic disease (eg, hydatidiform mole, choriocarcinoma), and germ cell tumors (eg, dysgerminomas). Dysgerminomas may also secrete lactate dehydrogenase and have distinctive “fried-egg” cells with large, round nuclei surrounded by clear cytoplasm.
(Choice D) Granulosa cell tumors of the ovary are sex cord–stromal neoplasms that secrete estrogen and inhibin. Pathology findings include Call-Exner bodies with atypical granulosa cells containing coffee-bean nuclei.
(Choice F) Testosterone is secreted by Sertoli-Leydig cell tumors of the ovary. These rare sex cord–stromal neoplasms typically appear as tubules composed of Sertoli cells with interspersed eosinophilic Leydig cells and surrounding fibrous stroma.
Educational objective:
Epithelial ovarian cancer is the most common ovarian malignancy. Histologic findings include anaplasia of epithelial cells with invasion into the stroma and multiple papillary formations with cellular atypia. Epithelial ovarian tumors are associated with elevated cancer antigen 125, which can be used as a serum marker for this condition.
Answer D
This obese patient with postmenopausal bleeding most likely has endometrial hyperplasia or cancer. The most common risk factor for endometrial hyperplasia/cancer is chronic unopposed estrogen exposure, which is associated with obesity, early menarche, late menopause, and chronic anovulation.
Postmenopausal women have decreased ovarian function (ie, low estrogen and progesterone production), resulting in cessation of endometrial proliferation and subsequent amenorrhea. However, small amounts of androgens continue to be produced in the ovaries and adrenal glands after menopause. In obese women, these androgens (eg, androstenedione) are readily converted to estrogens (eg, estrone) by the aromatase enzyme found in adipose tissue.
The increased peripheral production of estrogens in adipose tissue and the decrease in sex-hormone binding globulin levels (that normally occurs with menopause) lead to elevated free estrogen levels (Choice C). However, ovarian progesterone production remains low; therefore, the unopposed estrogen causes unregulated endometrial proliferation and subsequent endometrial hyperplasia or cancer, which often presents as postmenopausal or abnormal uterine bleeding.
(Choice A) Hyperprolactinemia due to autonomous pituitary secretion of prolactin (ie, pituitary adenoma) causes negative feedback to the hypothalamus. This results in decreased hypothalamic GnRH secretion, decreased pituitary FSH and LH secretion, and decreased estrogen and progesterone levels. Therefore, premenopausal women often have signs of hyperprolactinemia (eg, galactorrhea) and hypoestrogenism (eg, amenorrhea). In postmenopausal women, the most common symptom is tumor mass effect (eg, headache, bitemporal hemianopsia).
(Choice B) Endometriosis, the ectopic implantation of endometrial glands and stroma, typically causes painful menses (ie, dysmenorrhea) due to inflamed tissue on the peritoneum. Endometriosis is uncommon after menopause because it requires high premenopausal estrogen levels that do not occur even in obese women.
(Choice E) Suppression of hypothalamic GnRH secretion (ie, hypothalamic hypogonadism) most commonly occurs in women with severe caloric restriction (eg, anorexia), excessive energy expenditure (eg, female athlete triad), or stress. The decreased GnRH secretion results in decreased pituitary FSH and LH secretion and subsequent decreased ovarian estrogen and progesterone production. Therefore, patients typically have amenorrhea rather than postmenopausal bleeding.
Educational objective:
Endometrial hyperplasia and cancer often present with postmenopausal bleeding. A common risk factor for endometrial cancer is obesity due to the peripheral aromatization of androgens to estrogens in adipose tissue, which leads to chronic unopposed estrogen exposure and uncontrolled endometrial tissue proliferation.
Answer D
Human papillomavirus (HPV) can infect cervical epithelial cells and cause disordered growth (ie, dysplasia) known as cervical intraepithelial neoplasia (CIN), which can then progress to invasive cervical cancer. Regular cervical cancer screening with cytology (ie, Pap test) can help identify dysplasia earlier; further evaluation (eg, colposcopy, biopsy) is performed if cytology reveals certain squamous or glandular abnormalities.
This patient has had 2 abnormal Pap test results and now has a tissue biopsy revealing high-grade CIN. The CIN grade refers to the depth of epithelial dysplasia on histopathology. Dysplasia, which appears as atypical, immature-appearing squamous cells with enlarged, pleomorphic, hyperchromatic nuclei, begins at the basal epithelial layer and extends toward the epithelial surface:
Low-grade CIN (ie, CIN 1) means that dysplasia is confined to the lower third of the cervical epithelium; most cases regress spontaneously once the HPV infection is cleared by the immune system (Choice B).
In contrast, high-grade CIN (ie, CIN 2 or CIN 3) indicates that dysplastic epithelial cells have advanced beyond the lower one third of the epithelium and show extension toward the epithelial surface (sometimes involving the entire thickness of the epithelium, known as carcinoma in situ). High-grade CIN has a higher risk of progression to invasive carcinoma.
Basement membrane invasion, a histologic finding that describes the extension of atypical cells below the epithelium (eg, nests of atypical cells in the subepithelial stroma), is consistent with invasive cervical cancer (Choice E).
(Choice A) Atypical glandular cells invading the basement membrane describes cervical adenocarcinoma, derived from the mucus-secreting columnar epithelium of the endocervix. This patient has a diagnosis of high-grade CIN, which is a squamous (not glandular) intraepithelial lesion.
(Choice C) Perinuclear vacuolization (ie, koilocytic change) indicates active HPV infection and may be present with or without other dysplastic changes. Although koilocytes may be seen in this patient’s biopsy, this finding alone is not diagnostic of high-grade CIN.
Educational objective:
Human papillomavirus infection of basal cervical epithelial cells can cause dysplasia known as cervical intraepithelial neoplasia (CIN). CIN is classified as low-grade (if involving the lower one third of the epithelium) or high-grade (if extending above the lower one third). Basement membrane invasion signifies invasive cancer.
Answer E
This postmenopausal patient’s ovarian mass, abdominal distension, and elevated cancer antigen 125 (CA-125) level are consistent with epithelial ovarian cancer (EOC). Patients often have advanced disease at the initial presentation because symptoms (eg, decreased appetite, weight loss) can be subtle. The most likely pathogenesis of EOC is repeated injury and repair to the ovarian surface, which makes surface epithelial cells susceptible to malignant transformation (ie, acquiring oncogenic mutations).
The most common cause of injury is ovulation, which requires rupture of an ovarian follicle to release an oocyte. Therefore, patients with an increased lifetime number of ovulatory cycles (eg, increasing age, nulliparity, early menarche) are at increased risk for EOC (Choice D). In contrast, protective factors typically suppress ovulation. Combined oral contraceptive pills contain estrogen and progestin, which provide negative feedback to the hypothalamic-pituitary-ovarian axis. The estrogen component likely decreases FSH secretion (that normally stimulates follicular growth), and the progestin component may suppress the LH surge (that normally triggers ovulation).
Although combined oral contraceptive pills may not prevent ovulation during every menstrual cycle, the overall decrease in lifetime number of ovulatory cycles provides protection against EOC. Other risk-reducing factors include multiparity and breastfeeding.
(Choices A and B) Consistent condom use and human papillomavirus (HPV) vaccination can reduce transmission of high-risk HPV, which in turn can reduce the risk of oropharyngeal, cervical, vaginal, vulvar, and anogenital epithelial cancers. Neither protects against ovarian cancer because ovarian cancer is not linked to HPV infection.
(Choice C) Antioxidants neutralize reactive oxygen species and free radicals, thereby decreasing their damage to cells. However, long-term antioxidant supplementation (eg, vitamin C) does not appear to decrease the risk of any cancer type, including ovarian cancer.
Educational objective:
The risk of epithelial ovarian cancer increases with the lifetime number of ovulatory cycles. Combined oral contraceptive pills, multiparity, and breastfeeding are protective factors because they suppress ovulation and decrease the lifetime number of ovulatory cycles.
A 48-year-old woman comes to the office due to heavy menstrual bleeding for the last several months. The patient has monthly menses with 5-6 days of heavy bleeding and passage of large blood clots and increased abdominal cramping. She has no significant medical history and has had 2 vaginal deliveries. Her family history is significant for endometrial cancer in her mother. BMI is 24 kg/m2. Vital signs are normal. Pelvic ultrasound shows a uterine mass. The patient undergoes a total abdominal hysterectomy; gross examination of the uterus is shown below:
The abnormal region indicated by the arrow is most likely to display which of the following microscopic findings?
A. Dysplastic squamocolumnar cells with areas of atypia
B. Ectopic endometrial glands and hemosiderin-laden macrophages
C. Hyperplastic proliferation of irregular endometrial glands
D. Infiltration of the stroma by high-grade serous carcinoma
E. Monoclonal proliferation of myocytes and fibroblasts
Answer E
This patient with heavy menses and a uterine mass has a uterine leiomyoma, also known as a fibroid. Fibroids are common, benign tumors arising from smooth muscle cells and fibroblasts that can grow in a variety of sizes and locations within the uterine myometrium, resulting in variable clinical presentations. This patient has an intramural fibroid (within the uterine wall), which can increase the endometrial surface area (due to mass effect) and result in heavy menses.
Patients with symptomatic uterine fibroids are often treated surgically with a hysterectomy. Grossly, fibroids appear as discrete, yellow-gray tumors with a thin pseudocapsule that separates the fibroid from the normal uterine myometrium. Diagnosis is confirmed with microscopy, which typically reveals monoclonal proliferation of myocytes and fibroblasts because each fibroid arises from a single progenitor smooth muscle cell. Due to their benign nature, fibroid myocytes are uniform in size and shape and have minimal mitotic figures.
(Choice A) Patients with cervical cancer are often asymptomatic or have irregular, postcoital spotting rather than heavy menses. Cervical cancer is typically found in the cervical transformation zone (rather than the uterine myometrium) and microscopy shows dysplastic squamocolumnar cells with areas of atypia.
(Choice B) Patients with endometriosis typically present with painful menses (ie, dysmenorrhea); however, there are usually endometrial tissue implants outside the uterus rather than an intrauterine mass. Light microscopy typically reveals ectopic endometrial glands and hemosiderin-laden macrophages.
(Choice C) Patients with endometrial hyperplasia or cancer typically present with irregular, heavy menses and a thickened endometrium (rather than a mass in the myometrium). Histopathology typically reveals hyperplastic proliferation of irregular endometrial glands.
(Choice D) Microscopy of ovarian cancer typically reveals infiltration of the stroma by high-grade serous carcinoma. Ovarian cancer is unlikely in this patient as it typically causes an adnexal mass rather than a solitary intrauterine mass.
Educational objective:
Uterine leiomyomas (ie, fibroids) are common, benign tumors arising from the uterine myometrium that occur due to monoclonal proliferation of myocytes and fibroblasts.